Belpointe Asset Management LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1721242
RENO, NV
Position in REGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$1,478,413
-$231,439 QoQ
Shares Held
2,371
+7.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#581
of 1,322 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Belpointe Asset Management LLC holds $13,833,173 across 13 Biotechnology names. REGN ranks #5 (10.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
25,423 | $2,881,951 | |
| 2 | TGTX |
Tg Therapeutics, Inc.
|
50,719 | $2,786,501 | |
| 3 | MRNA |
Moderna, Inc.
|
32,598 | $2,282,837 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,741 | $1,858,266 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
2,371 | $1,478,413 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
15,682 | $1,227,430 | |
| 7 | CADL |
Candel Therapeutics, Inc.
|
52,778 | $543,613 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,485 | $307,543 |
All Filings in REGN
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,478,413 | 2,371 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $1,709,852 | 2,213 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $1,735,163 | 2,248 | Shares | Sole | 2026-01-27 | |
| 2025-03-31 | $641,206 | 1,011 | Shares | Other | 2025-05-20 | |
| 2024-12-31 | $1,403,290 | 1,970 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $1,937,435 | 1,843 | Shares | Other | 2024-11-13 | |
| 2024-06-30 | $1,880,292 | 1,789 | Shares | Other | 2024-08-02 | |
| 2024-03-31 | $1,264,711 | 1,314 | Shares | Other | 2024-05-08 | |
| 2023-12-31 | $288,957 | 329 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $668,243 | 812 | Shares | Other | 2023-11-15 | |
| 2023-06-30 | $268,015 | 373 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $856,180 | 1,042 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $795,803 | 1,103 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $863,154 | 1,253 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $383,643 | 649 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $456,068 | 653 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $1,120,948 | 1,775 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $3,207,454 | 5,300 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,372,891 | 2,458 | Shares | Sole | 2021-08-09 | |
| 2021-03-31 | $2,129,603 | 4,501 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $203,389 | 421 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $234,547 | 419 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $650,466 | 1,043 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $516,610 | 1,058 | Shares | Sole | 2020-07-20 | |
| No filing history on record for this holder in this stock. | ||||||